Logo image of XGR2.DE

COMPASS GROUP PLC (XGR2.DE) Stock Fundamental Analysis

FRA:XGR2 - Deutsche Boerse Ag - GB00BD6K4575 - Common Stock - Currency: EUR

30.51  -0.41 (-1.33%)

Fundamental Rating

5

Overall XGR2 gets a fundamental rating of 5 out of 10. We evaluated XGR2 against 58 industry peers in the Hotels, Restaurants & Leisure industry. XGR2 has an average financial health and profitability rating. XGR2 is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

XGR2 had positive earnings in the past year.
In the past year XGR2 had a positive cash flow from operations.
XGR2 had positive earnings in each of the past 5 years.
In the past 5 years XGR2 always reported a positive cash flow from operatings.
XGR2.DE Yearly Net Income VS EBIT VS OCF VS FCFXGR2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

XGR2 has a better Return On Assets (5.77%) than 74.14% of its industry peers.
XGR2 has a better Return On Equity (20.56%) than 77.59% of its industry peers.
XGR2 has a better Return On Invested Capital (12.83%) than 81.03% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for XGR2 is in line with the industry average of 10.94%.
The last Return On Invested Capital (12.83%) for XGR2 is above the 3 year average (12.27%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.77%
ROE 20.56%
ROIC 12.83%
ROA(3y)6.39%
ROA(5y)4.49%
ROE(3y)21.7%
ROE(5y)15.03%
ROIC(3y)12.27%
ROIC(5y)9.04%
XGR2.DE Yearly ROA, ROE, ROICXGR2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

XGR2 has a Profit Margin (3.34%) which is comparable to the rest of the industry.
XGR2's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 6.05%, XGR2 perfoms like the industry average, outperforming 48.28% of the companies in the same industry.
XGR2's Operating Margin has been stable in the last couple of years.
With a decent Gross Margin value of 72.66%, XGR2 is doing good in the industry, outperforming 70.69% of the companies in the same industry.
In the last couple of years the Gross Margin of XGR2 has remained more or less at the same level.
Industry RankSector Rank
OM 6.05%
PM (TTM) 3.34%
GM 72.66%
OM growth 3Y19.73%
OM growth 5Y-1.19%
PM growth 3Y18.8%
PM growth 5Y-6.03%
GM growth 3Y-1.02%
GM growth 5Y0.32%
XGR2.DE Yearly Profit, Operating, Gross MarginsXGR2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so XGR2 is still creating some value.
The number of shares outstanding for XGR2 has been reduced compared to 1 year ago.
The number of shares outstanding for XGR2 has been increased compared to 5 years ago.
The debt/assets ratio for XGR2 has been reduced compared to a year ago.
XGR2.DE Yearly Shares OutstandingXGR2.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
XGR2.DE Yearly Total Debt VS Total AssetsXGR2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

XGR2 has an Altman-Z score of 4.51. This indicates that XGR2 is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.51, XGR2 belongs to the top of the industry, outperforming 87.93% of the companies in the same industry.
XGR2 has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as XGR2 would need 3.51 years to pay back of all of its debts.
XGR2 has a better Debt to FCF ratio (3.51) than 77.59% of its industry peers.
XGR2 has a Debt/Equity ratio of 0.71. This is a neutral value indicating XGR2 is somewhat dependend on debt financing.
XGR2 has a better Debt to Equity ratio (0.71) than 62.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 3.51
Altman-Z 4.51
ROIC/WACC1.48
WACC8.68%
XGR2.DE Yearly LT Debt VS Equity VS FCFXGR2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

XGR2 has a Current Ratio of 0.74. This is a bad value and indicates that XGR2 is not financially healthy enough and could expect problems in meeting its short term obligations.
XGR2's Current ratio of 0.74 is on the low side compared to the rest of the industry. XGR2 is outperformed by 60.34% of its industry peers.
XGR2 has a Quick Ratio of 0.74. This is a bad value and indicates that XGR2 is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.67, XGR2 is not doing good in the industry: 63.79% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.67
XGR2.DE Yearly Current Assets VS Current LiabilitesXGR2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.70% over the past year.
The Earnings Per Share has been growing slightly by 6.94% on average over the past years.
XGR2 shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.35%.
XGR2 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.04% yearly.
EPS 1Y (TTM)9.7%
EPS 3Y59.19%
EPS 5Y6.94%
EPS Q2Q%9.32%
Revenue 1Y (TTM)21.35%
Revenue growth 3Y32.86%
Revenue growth 5Y11.04%
Sales Q2Q%8.18%

3.2 Future

The Earnings Per Share is expected to grow by 10.46% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.56% on average over the next years.
EPS Next Y13.94%
EPS Next 2Y12.61%
EPS Next 3Y11.78%
EPS Next 5Y10.46%
Revenue Next Year7.88%
Revenue Next 2Y8.01%
Revenue Next 3Y7.62%
Revenue Next 5Y6.56%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XGR2.DE Yearly Revenue VS EstimatesXGR2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20B 40B 60B
XGR2.DE Yearly EPS VS EstimatesXGR2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.99, the valuation of XGR2 can be described as expensive.
XGR2's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of XGR2 to the average of the S&P500 Index (26.82), we can say XGR2 is valued inline with the index average.
With a Price/Forward Earnings ratio of 23.06, XGR2 is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as XGR2.
XGR2's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.21.
Industry RankSector Rank
PE 27.99
Fwd PE 23.06
XGR2.DE Price Earnings VS Forward Price EarningsXGR2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

XGR2's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. XGR2 is more expensive than 62.07% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of XGR2 indicates a slightly more expensive valuation: XGR2 is more expensive than 62.07% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 35.03
EV/EBITDA 19.61
XGR2.DE Per share dataXGR2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates XGR2 does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of XGR2 may justify a higher PE ratio.
PEG (NY)2.01
PEG (5Y)4.04
EPS Next 2Y12.61%
EPS Next 3Y11.78%

4

5. Dividend

5.1 Amount

XGR2 has a Yearly Dividend Yield of 1.81%.
Compared to an average industry Dividend Yield of 2.90, XGR2 pays a bit more dividend than its industry peers.
XGR2's Dividend Yield is slightly below the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 1.81%

5.2 History

The dividend of XGR2 is nicely growing with an annual growth rate of 7.92%!
Dividend Growth(5Y)7.92%
Div Incr Years2
Div Non Decr Years2
XGR2.DE Yearly Dividends per shareXGR2.DE Yearly Dividends per shareYearly Dividends per share 2020 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

68.59% of the earnings are spent on dividend by XGR2. This is not a sustainable payout ratio.
The dividend of XGR2 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP68.59%
EPS Next 2Y12.61%
EPS Next 3Y11.78%
XGR2.DE Yearly Income VS Free CF VS DividendXGR2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
XGR2.DE Dividend Payout.XGR2.DE Dividend Payout, showing the Payout Ratio.XGR2.DE Dividend Payout.PayoutRetained Earnings

COMPASS GROUP PLC

FRA:XGR2 (8/1/2025, 7:00:00 PM)

30.51

-0.41 (-1.33%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)07-22 2025-07-22
Earnings (Next)11-25 2025-11-25/amc
Inst Owners75.21%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap51.79B
Analysts74.48
Price Target32.06 (5.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.81%
Yearly Dividend0.49
Dividend Growth(5Y)7.92%
DP68.59%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.93%
PT rev (3m)-2.12%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-0.33%
Valuation
Industry RankSector Rank
PE 27.99
Fwd PE 23.06
P/S 1.41
P/FCF 35.03
P/OCF 19.08
P/B 8.65
P/tB N/A
EV/EBITDA 19.61
EPS(TTM)1.09
EY3.57%
EPS(NY)1.32
Fwd EY4.34%
FCF(TTM)0.87
FCFY2.85%
OCF(TTM)1.6
OCFY5.24%
SpS21.7
BVpS3.53
TBVpS-1.75
PEG (NY)2.01
PEG (5Y)4.04
Profitability
Industry RankSector Rank
ROA 5.77%
ROE 20.56%
ROCE 17.79%
ROIC 12.83%
ROICexc 13.29%
ROICexgc 51.51%
OM 6.05%
PM (TTM) 3.34%
GM 72.66%
FCFM 4.01%
ROA(3y)6.39%
ROA(5y)4.49%
ROE(3y)21.7%
ROE(5y)15.03%
ROIC(3y)12.27%
ROIC(5y)9.04%
ROICexc(3y)13.85%
ROICexc(5y)10.87%
ROICexgc(3y)61.26%
ROICexgc(5y)N/A
ROCE(3y)17.25%
ROCE(5y)12.72%
ROICexcg growth 3YN/A
ROICexcg growth 5Y-13.01%
ROICexc growth 3Y21.26%
ROICexc growth 5Y-3.92%
OM growth 3Y19.73%
OM growth 5Y-1.19%
PM growth 3Y18.8%
PM growth 5Y-6.03%
GM growth 3Y-1.02%
GM growth 5Y0.32%
F-Score5
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 3.51
Debt/EBITDA 1.47
Cap/Depr 189.38%
Cap/Sales 3.35%
Interest Coverage 9.51
Cash Conversion 94.24%
Profit Quality 120.09%
Current Ratio 0.74
Quick Ratio 0.67
Altman-Z 4.51
F-Score5
WACC8.68%
ROIC/WACC1.48
Cap/Depr(3y)128.05%
Cap/Depr(5y)112.59%
Cap/Sales(3y)2.96%
Cap/Sales(5y)3.17%
Profit Quality(3y)97.61%
Profit Quality(5y)110.19%
High Growth Momentum
Growth
EPS 1Y (TTM)9.7%
EPS 3Y59.19%
EPS 5Y6.94%
EPS Q2Q%9.32%
EPS Next Y13.94%
EPS Next 2Y12.61%
EPS Next 3Y11.78%
EPS Next 5Y10.46%
Revenue 1Y (TTM)21.35%
Revenue growth 3Y32.86%
Revenue growth 5Y11.04%
Sales Q2Q%8.18%
Revenue Next Year7.88%
Revenue Next 2Y8.01%
Revenue Next 3Y7.62%
Revenue Next 5Y6.56%
EBIT growth 1Y38.42%
EBIT growth 3Y59.08%
EBIT growth 5Y9.72%
EBIT Next Year53.52%
EBIT Next 3Y21.42%
EBIT Next 5Y16.27%
FCF growth 1Y42.28%
FCF growth 3Y44.48%
FCF growth 5Y8.35%
OCF growth 1Y49.08%
OCF growth 3Y38.18%
OCF growth 5Y9.66%